FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Amneal Pharmaceuticals Isotretinoin Capsules Recall

Isotretinoin Capsules, USP 10 mg

Amneal Pharmaceuticals, Inc. · Brookhaven, NY

Risk level
Class III
Reported by FDA
Nov 20, 2019
Recall ID
D-0321-2020
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled Isotretinoin Capsules starting Oct 16, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0321-2020 on Nov 20, 2019. Reason: Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.

Product description

Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3

Lot numbers, UPCs & expiration codes

Batch Numbers: BL10917, BL11017, BL11117, Exp. date 11/2019

Where it was sold

Recalled product was distributed to retailers and wholesalers who may have further distribute the product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0321-2020
Classification
Class III
Status
Terminated
Recall initiated
Oct 16, 2019
FDA report date
Nov 20, 2019
Quantity
2460 cartons/3 blister cards/10 capsules each
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0321-2020, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Terminated
Country
United States
Event ID
84073
Address
50 Horseblock Rd
Code information
Batch Numbers: BL10917, BL11017, BL11117, Exp. date 11/2019
Postal code
11719-9509
Report date
Nov 20, 2019
Product type
Drugs
Recall number
D-0321-2020
Classification
Class III
Recalling firm
Amneal Pharmaceuticals, Inc.
Product quantity
2460 cartons/3 blister cards/10 capsules each
Termination date
Nov 9, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3
Distribution pattern
Recalled product was distributed to retailers and wholesalers who may have further distribute the product.
Recall initiation date
Oct 16, 2019
Initial firm notification
Letter
Center classification date
Nov 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0321-2020, published Nov 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls